Kehua Bio signs investment agreement for production base

Shanghai Kehua Bio-Engineering (SZSE:002022) announced that it has signed an investment cooperation agreement with the Xi'an Economic and Technological Development Zone Administrative Committee. The agreement outlines Kehua Bio's plans to invest in a medical equipment and testing reagent production base along with a medical industry incubation and innovation center. The project will occupy approximately 90 acres, split into two phases. Phase one involves a 50-acre production base for chemiluminescence products, medical devices, and testing reagents. Phase two will be a 40-acre medical industry incubation and innovation center. The company plans to establish a separate legal entity in the Xi'an Economic and Technological Development Zone to manage the project.